))
Activist Investing Today: Eldar on Anti-Activist Pill Evolution
Manage episode 484433930 series 3667463
Content provided by The Deal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Deal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
When corporations install anti-activist poison pills they are less likely to implement new share buybacks and their operationally-focused capital expenditures tend to be higher, UC Berkeley School of Law professor Ofer Eldar explains.
307 episodes
Share
